INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) shares fell 1.7% during mid-day trading on Tuesday . The company traded as low as $0.68 and last traded at $0.68. 109,447 shares traded hands during trading, a decline of 92% from the average session volume of 1,449,883 shares. The stock had previously closed at $0.70.
INVO Bioscience Trading Down 1.7 %
The business has a 50-day moving average of $0.81 and a 200-day moving average of $0.92.
INVO Bioscience (NASDAQ:INVO – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($0.62) earnings per share (EPS) for the quarter. The firm had revenue of $1.84 million during the quarter.
About INVO Bioscience
INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Featured Articles
- Five stocks we like better than INVO Bioscience
- Health Care Stocks Explained: Why You Might Want to Invest
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What does consumer price index measure?
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- 3 Monster Growth Stocks to Buy Now
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
